Антимикробная терапия тяжелых «гражданских» интраабдоминальных инфекций: современный подход к эмпирической антибиотикотерапии

Литература:

1. «Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017» Jean-Louis Vincent, MD, PhD, Yasser Sakr, MD, PhD, Mervyn Singer, MB, BS, Ignacio Martin-Loeches, MD, Flavia R. Machado, MD, PhD, John C. Marshall, MD, Simon Finfer, MB, BS, Paolo Pelosi, MD, Luca Brazzi, MD, PhD, Dita Aditianingsih, MD, PhD, Jean-François Timsit, MD, PhD Bin Du, MD, Xavier Wittebole, MD, Jan Máca, MD, Santhana Kannan, MD, Luis A. Gorordo-Delsol, MD, Jan J. De Waele, MD, Yatin Mehta, MD, Marc J. M. Bonten, MD, Ashish K. Khanna, MD, Marin Kollef, MD, Mariesa Human, RN, and Derek C. Angus, MD, for the EPIC III Investigators//JAMA. 2020 Apr 21; 323(15): 1478–1487.doi: 10.1001/jama.2020.2717
2. «Infections of respiratory or abdominal origin in ICU patients: what are the differences?» Volakli E, Spies C, Michalopoulos A, Groeneveld AB, Sakr Y, Vincent JL.// Crit Care. 2010;14:R32. doi: 10.1186/cc8909.
3. «Prevalence, predictors, and consequences of inappropriate empiric antimicrobial therapy for complicated urinary tract and intra-abdominal infections in Winnipeg hospitals» Christiaan H Righolt, Philippe Lagace-Wiens, Salaheddin M Mahmud //Diagn Microbiol Infect Dis. 2020 Jan;96(1):114891.doi: 10.1016/j.diagmicrobio.2019.114891.
4. «Systematic review and meta-analysis of the efficacy of appropriate empiric anti-enterococcal therapy for intra-abdominal infection.» Zhang J, Yu W-Q, Chen W, Wei T, Wang C-W, Zhang J-Y, et al.//Surg Infect (Larchmt). 2021;22:131–43.
5. «Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.» Vogelaers, D., Blot, S., Van den Berge, A., Montravers, P., Francois, G., Labeau, S., Lipman, J. (2021).// Drugs, 81(9), 1065–1078. doi:10.1007/s40265-021-01534-
6. «Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project» Stijn Blot, Massimo Antonelli, Kostoula Arvaniti, Koen Blot, Ben Creagh-Brown, Dylan de Lange, Jan De Waele, Mieke Deschepper, Yalim Dikmen, George Dimopoulos, Christian Eckmann, Guy Francois, Massimo Girardis, Despoina Koulenti, Sonia Labeau, Jeffrey Lipman, Fernando Lipovestky, Emilio Maseda, Philippe Montravers, Adam Mikstacki, José-Artur Paiva, Cecilia Pereyra, Jordi Rello, Jean-Francois Timsit, Dirk Vogelaers, and the Abdominal Sepsis Study (AbSeS) group on behalf of the Trials Group of the European Society of Intensive Care Medicine // Intensive Care Med. 2019; 45(12): 1703–1717.
7. European Centre for Disease Prevention and Control. Surveillance atlas of infectious diseases. atlas.ecdc.europa.eu/public/index.aspx. Accessed 1 Oct 2020.
8. «Prevalence, underlying causes, and preventability of Sepsis-Associated Mortality in US Acute Care Hospitals.» Rhee C, Jones TM, Hamad Y, Pande A, Varon J, O’Brien C, Anderson DJ, Warren DK, Dantes RB, Epstein L, Klompas M, Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program.// JAMA Netw Open. 2019;2(2):e187571
9. «Association between time to source control in Sepsis and 90-day mortality.» Reitz KM, Kennedy J, Li SR, Handzel R, Tonetti DA, Neal MD, Zuckerbraun BS, Hall DE, Sperry JL, Angus DC, Tzeng E, Seymour CW.// JAMA Surg. 2022;13:e222761
10. «Source control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines» Federico Coccolini,corresponding, Massimo Sartelli, Robert Sawyer, Kemal Rasa, Bruno Viaggi, Fikri Abu-Zidan, Kjetil Soreide, Timothy Hardcastle, Deepak Gupta, Cino Bendinelli, Marco Ceresoli, Vishal G. Shelat, Richard ten Broek, Gian Luca Baiocchi, Ernest E. Moore Ibrahima Sall, Mauro Podda, Luigi Bonavina, Igor A. Kryvoruchko, Philip Stahel, Kenji Inaba, Philippe Montravers, Boris Sakakushev, Gabriele Sganga, Paolo Ballestracci, Manu L. N. G. Malbrain, Jean-Louis Vincent, Manos Pikoulis, Solomon Gurmu Beka, Krstina Doklestic, Massimo Chiarugi, Marco Falcone, Elena Bignami, Viktor Reva, Zaza Demetrashvili, Salomone Di Saverio, Matti Tolonen, Pradeep Navsaria, Miklosh Bala, Zsolt Balogh, Andrey Litvin, Andreas Hecker, Imtiaz Wani, Andreas Fette, Belinda De Simone, Rao Ivatury, Edoardo Picetti, Vladimir Khokha, Edward Tan, Chad Ball, Carlo Tascini, Yunfeng Cui, Raul Coimbra, Michael Kelly, Costanza Martino, Vanni Agnoletti, Marja A. Boermeester, Nicola De’Angelis, Mircea Chirica, Walt L. Biffl, Luca Ansaloni, Yoram Kluger, Fausto Catena, and Andrew W. Kirkpatrick// World J Emerg Surg. 2023; doi: 10.1186/s13017-023-00509-4
11. «The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection» John E. Mazuski, Jeffrey M. Tessier, Addison K. May, Robert G. Sawyer, Evan P. Nadler, Matthew R. Rosengart, Phillip K. Chang, Patrick J. O’Neill, Kevin P. Mollen, Jared M. Huston, Jose J. DiazJr, and Jose M. Prince // Surgical InfectionsVol. 18, No. 1 doi.org/10.1089/sur.2016.261
12. «Pharmacokinetics of piperacillin-tazobactam in plasma, peritoneal fluid and peritoneum of surgery patients, and dosing considerations based on site-specific pharmacodynamic target attainment» Naoki Murao, Hiroki Ohge, Kazuro Ikawa, Yusuke Watadani, Shinnosuke Uegami, Norifumi Shigemoto, Norimitsu Shimada, Raita Yano, Toshiki Kajihara, Kenichiro Uemura , Yoshiaki Murakami, Norifumi Morikawa, Taijiro Sueda// Int J Antimicrob Agents . 2017 Sep;50(3):393-398. doi: 10.1016/j.ijantimicag.
13. «Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study» Mitchell S Buckley, Ivan A Komerdelj, Paul A D’Alessio, Pooja Rangan, Sumit K Agarwal, Nicole C Tinta, Brandon K Martinez, Delia S Ziadat, Melanie J Yerondopoulos, Emir Kobic, Sandra L Kane-Gill // J Crit Care. 2022 Feb;67:134-140. doi: 10.1016/j.jcrc.2021.10.018.
14. «Clinical Microbiology And Infectious Diseases: An Illustrated Colour Text» by W. John Spicer / Edition 2 p.22
15. «Molecular Medical Microbiology.» Chapter 51 Bacteroides p.918 by Sheila Patrick DOI: dx.doi.org/10.1016/B978-0-12-397169-2.00051-2
16. «Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience» Nagy, E. Urbán, Carl Erik Nord on behalf of the ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bact //Clinical Microbiology and Infection, 2011 March,Volume 17 Number 3, p. 371 — 379
17. «Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.» Li C, Kuti JL, Nightingale CH, Mansfield DL, Dana A, Nicolau DP.//J Antimicrob Chemother. 2005 Aug;56(2):388-95. doi: 10.1093/jac/dki243.
18. «The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How.» Karaiskos I, Lagou S, Pontikis K, Rapti V and Poulakou G (2019)//Front. Public Health 7:151. doi: 10.3389/fpubh.2019.00151
19. «Antimicrobial resistance in ESKAPE pathogens.» De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. 2020 //Clin Microbiol Rev 33:e00181-19. org/10.1128/CMR.00181-19.
20. «Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, Wilson APR. /British Infection Association Joint Working Party.// J Antimicrob Chemother. 2018 Mar 1;73(suppl_3):iii2-iii78. doi: 10.1093/jac/dky027. PMID: 29514274.
21. « European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)». Paul M, Carrara E, Retamar P, Tängdén T, Bitterman R, Bonomo RA, de Waele J, Daikos GL, Akova M, Harbarth S, Pulcini C, Garnacho-Montero J, Seme K, Tumbarello M, Lindemann PC, Gandra S, Yu Y, Bassetti M, Mouton JW, Tacconelli E, Rodríguez-Baño //Clin Microbiol Infect. 2022 Apr;28(4):521-547. doi: 10.1016/j.cmi.2021.11.025.
22. «Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).» Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2022//Clin Infect Dis. 2022 Aug 25;75(2):187-212. doi: 10.1093/cid/ciac268.
23. «Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.» Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America//Clin Infect Dis. 2022 Jul 6;74(12):2089-2114. doi: 10.1093/cid/ciab1013.
24. «Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections.» Bassetti M, Garau J.//J Antimicrob Chemother. 2021 Nov 22;76(Suppl 4):iv23-iv37. doi: 10.1093/jac/dkab352,
25. «Enterococcal resistance—an overview.» Marothi YA, Agnihotri H, Dubey D.//Indian J Med Microbiol. 2005 Oct;23(4):214-9.
26. «Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study» Mitchell S Buckley, Ivan A Komerdelj, Paul A D’Alessio, Pooja Rangan, Sumit K Agarwal, Nicole C Tinta, Brandon K Martinez, Delia S Ziadat, Melanie J Yerondopoulos , Emir Kobic, Sandra L Kane-Gill// J Crit Care. 2022 Feb;67:134-140. doi: 10.1016/j.jcrc.2021.10.018.
27. «Compliance with an empirical antimicrobial protocol improves the outcome of complicated intra-abdominal infections: a prospective observational study»M. Guilbart, E. Zogheib, A. Ntouba, L. Rebibo, J. M. Régimbeau, Y. Mahjoub and H. Dupont// Br J Anaesth. 2016 Jul; 117(1): 66–72. doi: 10.1093/bja/aew117